May 13, 2023

In the context of our collaboration with various stakeholders in the T2EVOLVE project, we are happy to share that the T2EVOLVE-QUALITOP European patient survey on CAR T-cell therapy is now open !

This survey will help to understand patients’ experiences with CAR T-cell therapy, evaluate the impact of this treatment on quality of life and identify unmet needs. With this information we aim to improve quality of life in patients receiving CAR T-cell therapy and their carers by optimizing support and improving the CAR T-cell treatment journey.

All European adult patients (≥ 18 years) who received CAR T-cell therapy for a hematologic malignancy (no specific indication required) can participate by filling in a digital survey.

Now, we need you!

If you are a patient treated with CAR T-cell therapy for a hematologic malignancy in Europe we would like to invite you to share your experiences with us by participating in our survey!

If you are not a patient but you are in close contact with patients who receive CAR T-cell therapy (e.g. a patient association, hematologist, nurse or other healthcare professional) we would like to invite you to help us by sharing this survey with patients!

Information: https://t2evolve.com/european-patient-survey-on-car-t-cell-therapy-to-gain-insights-into-patients-experiences-quality-of-life-and-unmet-needs/

You can use the attached QR code or the following link to access the survey (password: t2evolve): https://t2evolve.fyi/patientsurvey

The survey is available in English, French, German, Spanish, Italian, Portuguese and Dutch.

The survey will be open until the 31st July 2023.

Translated brochures:

T2EVOLVE-QUALITOP_Encuesta a pacientes europeos sobre la terapia con células CAR-T

T2EVOLVE-QUALITOP_Enquête européenne auprès des patients sur la thérapie par cellules CAR-T

T2EVOLVE-QUALITOP_Europäische Patientenbefragung zur CAR-T-Zell-Therapie

T2EVOLVE-QUALITOP_European patient survey on CAR T-cell therapy

T2EVOLVE-QUALITOP_Europese patiëntenenquête over CAR T-celtherapie

T2EVOLVE-QUALITOP_Inquérito a doentes europeus submetidos a terapêutica com células CAR T

T2EVOLVE-QUALITOP_Sondaggio europeo per pazienti ematologici trattati con terapia CAR-T